T1	Participants 45 104	FIGO stage I endometrial carcinoma with myometrial invasion
T2	Participants 154 213	FIGO stage I endometrial carcinoma with myometrial invasion
T3	Participants 658 728	Of the 62 patients who entered the study, 51 were considered evaluable
T4	Participants 798 825	Five patients had a relapse
T5	Participants 1160 1229	patients with deep myometrial invasion and undifferentiated carcinoma
T6	Participants 1322 1381	FIGO stage I endometrial carcinoma with myometrial invasion
